Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
FENC

FENC - Fennec Pharmaceuticals Inc Stock Price, Fair Value and News

$8.99+0.14 (+1.58%)
Market Closed as of 12 Jun 2026, 04:00 pm ET

61/100

FENC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

61/100

FENC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

FENC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FENC Price Action

Last 7 days

3.3%

Last 30 days

32.8%

Last 90 days

19.6%

Trailing 12 Months

8.1%

FENC RSI Chart

FENC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FENC Valuation

Market Cap

310.5M

Price/Earnings (Trailing)

-37.08

Price/Sales (Trailing)

6.09

EV/EBITDA

-33.21

Price/Free Cashflow

-53.76

FENC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

FENC Fundamentals

FENC Revenue

Revenue (TTM)

51.0M

Rev. Growth (Yr)

72.64%

Rev. Growth (Qtr)

9.66%

FENC Earnings

Earnings (TTM)

-8.4M

Earnings Growth (Yr)

117.25%

Earnings Growth (Qtr)

104.2%

FENC Profitability

EBT Margin

-18.89%

Return on Equity

-22.23%

Return on Assets

-11.66%

Free Cashflow Yield

-1.86%

FENC Investor Care

Shares Dilution (1Y)

25.18%

Diluted EPS (TTM)

-0.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202651.0M000
202530.9M33.3M38.8M44.6M
202445.0M48.9M49.3M47.5M
20236.5M11.4M16.3M21.3M
20220001.5M
2020000200.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Fennec Pharmaceuticals Inc

FENC
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
 CEO
 WEBSITEfennecpharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES36

Fennec Pharmaceuticals Inc Frequently Asked Questions

FENC is the stock ticker symbol of Fennec Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jun 12 2026, market cap of Fennec Pharmaceuticals Inc is 310.52 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Jun 12 2026, FENC's PE ratio (Price to Earnings) is -37.08 and Price to Sales (PS) ratio is 6.09. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FENC PE ratio will change depending on the future growth rate expectations of investors.